Why You Should Look at Aratana Therapeutics' Stock on Monday?
Financial News, Daily Stock Alerts, Penny Stock Alerts at Galaxy Stocks Subscribe to RSS
  • Aratana Ther...
    Aratana Therapeutics, Inc. (Nasdaq:PETX) closed at ...

    Aratana Therapeutics (PETX) Potential Dogs Inappetence Therapy; BioLineRx (BLRX) Outperformed Session

    Aratana Therapeutics, Inc. (Nasdaq:PETX) closed at $13.44 per share, up $0.24 (or +1.82%) on Friday's market activity. After the closing bell, ...
  • Zoetis (NYSE...
    Zoetis Inc. (NYSE:ZTS) climbed $5.67 (or ...

    Zoetis (NYSE:ZTS) At All-time High Levels; Strong Perspectives on Veracyte (Nasdaq:VCYT)

    Zoetis Inc. (NYSE:ZTS) climbed $5.67 (or +11.41%) to $55.38 per share on Thursday's trading session. The price of ZTS stock continued ...
  • Momentum Fac...
    Shares of Amedisys Inc. (Nasdaq:AMED) touched ...

    Momentum Factors: Amedisys Inc (Nasdaq:AMED), ConAgra Foods Inc (NYSE:CAG), Fiserv Inc (Nasdaq:FISV)

    Shares of Amedisys Inc. (Nasdaq:AMED) touched a new 52-week high of $42.98 on Friday's trading session after brokerage firm Jefferies ...
  • Synergy Phar...
    Shares of Synergy Pharmaceuticals Inc. (Nasdaq:SGYP) skyrocketed ...

    Synergy Pharmaceuticals (SGYP) Soars on Trial Results, Joe’s Jeans (JOEZ) Impressive Intraday Bounce

    Shares of Synergy Pharmaceuticals Inc. (Nasdaq:SGYP) skyrocketed to touch a new 52-week high of $7.90 on Wednesday's trading session as the ...
  • Expectatives...
    Shares of Aoxing Pharmaceutical Company Inc. ...

    Expectatives Effect: Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN), Diana Shipping Inc (NYSE:DSX)

    Shares of Aoxing Pharmaceutical Company Inc. (NYSEMKT:AXN) soared to touch a new 52-week high of $2.98 on Monday's trading session as ...
  • Amarin Corp ...
    Shares of Amarin Corporation plc (Nasdaq:AMRN) ...

    Amarin Corp plc (ADR) (AMRN) Soars on Legal Victory Over FDA, Avago Technologies Ltd (AVGO) Posts Earnings Surprise

    Shares of Amarin Corporation plc (Nasdaq:AMRN) soared $0.37 (or +18.97%) to $2.32 on Thursday's trading session after the company said that ...
  • Impetus Indi...
    Shares of Cancer Genetics, Inc. (Nasdaq:CGIX) ...

    Impetus Indicators: Cancer Genetics Inc (Nasdaq:CGIX), Pain Therapeutics Inc (Nasdaq:PTIE), Public Storage (NYSE:PSA)

    Shares of Cancer Genetics, Inc. (Nasdaq:CGIX) surged on Tuesday's trading session after the company reported better-than-expected financial results, highlighted by ...
  • Strong Opera...
    Shares of Imperva Inc. (NYSE:IMPV) soared $8.87 ...

    Strong Operational Momentum: Imperva (NYSE:IMPV), NeoPhotonics (NYSE:NPTN), SolarEdge (Nasdaq:SEDG)

    Shares of Imperva Inc. (NYSE:IMPV) soared $8.87 (or +19.66%) to $53.98 on Friday's trading session after the company reported quarterly financial ...
  • Key Metrics ...
    Shares of Teradyne Inc. (NYSE:TER) surged ...

    Key Metrics Surpass Consensus: Teradyne Inc (NYSE:TER), Ellie Mae Inc (NYSE:ELLI), FirstEnergy Corp (NYSE:FE)

    Shares of Teradyne Inc. (NYSE:TER) surged $2.05 (or +11.23%) to $20.30 on Friday, after the company delivered better-than expected financial results with ...
  • At All-Time ...
    Shares of Skechers USA Inc. (NYSE:SKX) ...

    At All-Time High Levels on Earnings Effect: Skechers USA Inc (NYSE:SKX), Adeptus Health Inc (NYSE:ADPT)

    Shares of Skechers USA Inc. (NYSE:SKX) reached new lifetime high levels in early trading Thursday as the company delivered quarterly ...

Business Newsshow all business news articles

Featured Category not specified
Aratana Therapeutics (PETX) Potential Dogs Inappetence Therapy; BioLineRx (BLRX) Outperformed Session
Aratana Therapeutics (PETX) Potential Dogs Inappetence Therapy; BioLineRx (BLRX) Outperformed Session

Aratana Therapeutics, Inc. (Nasdaq:PETX) closed at $13.44 per share, up $0.24 (or +1.82%) on Friday’s market activity. After the closing bell, the company said that its drug capromorelin (AT-002) for treating inappetence in dogs was effective in a pivotal field effectiveness study. According to Aratana Therapeutics, client-owned dogs receiving capromorelin showed significant increases in appetite versus placebo in the study The

Zoetis (NYSE:ZTS) At All-time High Levels; Strong Perspectives on Veracyte (Nasdaq:VCYT)
Zoetis (NYSE:ZTS) At All-time High Levels; Strong Perspectives on Veracyte (Nasdaq:VCYT)

Zoetis Inc. (NYSE:ZTS) climbed $5.67 (or +11.41%) to $55.38 per share on Thursday’s trading session. The price of ZTS stock continued in the same trajectory to touch a record high in after-hours trading as a result of the upside momentum generated by a report indicating that the company had been approached about a takeover by Canadian drugmaker Valeant

David Davidovich Bets on Cleveland BioLabs (CBLI); MeetMe (MEET) Bullish Expectations
David Davidovich Bets on Cleveland BioLabs (CBLI); MeetMe (MEET) Bullish Expectations

Cleveland BioLabs, Inc. (Nasdaq:CBLI) disclosed in a regulatory filing ( FORM 8-K ) with the Securities and Exchange Commission a stock purchase agreement between the company and venture capital investor David Davidovich As part of the deal, the innovative biopharmaceutical companyagreed to issue and sell to the purchaser, subject to customary closing conditions, an aggregate of 6,459,948 shares

read more

NYSE Newsshow all nyse news articles

Featured Category not specified
CEOLIVE.TV Highlighted NovaBay Pharmaceuticals (NYSEMKT:NBY) i-Lid Cleanser In Interview With Dr. Kathryn Najafi-Tagol
CEOLIVE.TV Highlighted NovaBay Pharmaceuticals (NYSEMKT:NBY) i-Lid Cleanser In Interview With Dr. Kathryn Najafi-Tagol

NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY), a biopharmaceutical company that centers on non-antibiotic anti-infectives, announced recently that CEOLIVE.TV, an online service that gives news regarding companies to investors, made NovaBay’s important advance in eye care a highlight, through an interview with Kathryn Najafi-Tagol, M.D., the director and founder of the Eye Institute of Marin in San Rafael,

read more

Amex Newsshow all amex news articles

Featured Category not specified
read more

Sector Summaryshow all sector summary articles

Featured Category not specified
read more

NASDAQ Newsshow all nasdaq news articles

Featured Category not specified
read more

Sign Up!

Receive Our Newsletter!







http://galaxystocks.com/wp-content/uploads/top1.jpg



http://crwepressrelease.com/wp-content/uploads/2014/06/free_pr.jpg



http://galaxystocks.com/wp-content/uploads/submit_a_video_crwetube.jpg

CRWE Network


select Press Release database failed

Contacts and information

Social networks

Most popular categories

© 2015 Crown Equity Holdings Inc. All rights reserved.
%d bloggers like this: